ストックスクリーナーアプリを入手
1.67
2.45%
0.04
前日終値:
$1.63
開ける：
$1.63
24時間の取引高:
531.06K
Relative Volume:
0.69
時価総額：
$178.15M
収益：
$45.44M
当期純損益:
$-35.43M
株価収益率:
-4.9118
EPS:
-0.34
ネットキャッシュフロー:
$-25.39M
1週間 パフォーマンス:
+5.70%
1か月 パフォーマンス:
-2.34%
6か月 パフォーマンス:
-24.09%
1年 パフォーマンス:
-51.59%
1日の値動き範囲:
$1.61
$1.68
1週間の範囲:
$1.54
$1.805
52週間の値動き範囲:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
MXCT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.67 | 173.88M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | 開始されました | Stephens | Overweight |
| 2023-11-29 | 開始されました | Craig Hallum | Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-24 | 開始されました | BTIG Research | Buy |
| 2021-08-24 | 開始されました | Cowen | Outperform |
| 2021-08-24 | 開始されました | Stephens | Overweight |
| 2021-08-24 | 開始されました | Stifel | Buy |
| 2021-08-24 | 開始されました | Wedbush | Outperform |
| 2021-08-24 | 開始されました | William Blair | Outperform |
すべてを表示
Maxcyte Inc (MXCT) 最新ニュース
What drives MaxCyte Inc MYE0 stock priceRSI Overbought/Oversold & Daily Tips From Top Market Analysts - earlytimes.in
How MaxCyte Inc. (MYE0) stock reacts to fiscal policiesJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com
Can MaxCyte Inc. (MYE0) stock reach $200 price target2025 Major Catalysts & Weekly High Return Opportunities - newser.com
How MaxCyte Inc. (MYE0) stock behaves under inflation pressureEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
MaxCyte explores electroporation's role in cell therapy innovation - Traders Union
What Wall Street predicts for MaxCyte Inc. stock priceQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
MaxCyte drives cell engineering focus at Advanced Therapies USA - Traders Union
Can MaxCyte Inc. (MYE0) stock stage a strong rebound this quarter2025 Key Lessons & Daily Technical Forecast Reports - newser.com
Is MaxCyte Inc. stock a buy in volatile marketsJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
MaxCyte at Stephens Annual Investment Conference: Strategic Restructuring Amid Market Challenges By Investing.com - Investing.com Canada
Will MaxCyte Inc. stock split again soonTrade Risk Report & Daily Profit Maximizing Tips - newser.com
Is MaxCyte Inc. (MYE0) stock nearing a technical breakoutPortfolio Gains Summary & Community Consensus Picks - newser.com
What dividend safety rating applies to MaxCyte Inc. (MYE0) stockIPO Watch & Safe Capital Growth Trade Ideas - newser.com
How MaxCyte Inc. (MYE0) stock trades under stagflation2025 Performance Recap & Entry Point Strategy Guides - newser.com
Will MaxCyte Inc. (MYE0) stock see valuation expansionJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
How buyback programs support MaxCyte Inc. (MYE0) stockTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
What MACD signals say about MaxCyte Inc.July 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Real time scanner hits for MaxCyte Inc. explainedJuly 2025 Breakouts & Free Community Consensus Stock Picks - newser.com
Statistical indicators supporting MaxCyte Inc.’s strengthWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Will breakout in MaxCyte Inc. lead to full recoveryPortfolio Growth Summary & Real-Time Stock Price Movement Reports - newser.com
MaxCyte, Inc. (NASDAQ:MXCT) Q3 2025 Earnings Call Transcript - Insider Monkey
Backtesting results for MaxCyte Inc. trading strategiesPortfolio Growth Summary & AI Driven Stock Reports - newser.com
What sentiment indicators say about MaxCyte Inc. stockEarnings Recap Report & Technical Buy Zone Confirmations - Fundação Cultural do Pará
Maxcyte Inc (MXCT) 財務データ
収益
当期純利益
現金流量
EPS
5.84%
大文字化:
|
ボリューム (24 時間):